Insulin glargine (Lantus) shows no cancer, heart risks: study
01:55 EDT 12 Jun 2012 | Advanstar News Headlines
PARIS (Reuters) - Insulin glargine (Lantus;
Original Article: Insulin glargine (Lantus) shows no cancer, heart risks: study
More From BioPortfolio on "Insulin glargine (Lantus) shows no cancer, heart risks: study"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
